NCT01989312

Brief Summary

The aim of this study is to compare the combined ultrasound-guided supraclavicular brachial plexus block and distal median, radial, and ulnar nerve blocks, with supraclavicular block alone. Sixty two patients undergoing upper extremity surgery will be randomized to supraclavicular only (Group S, n=31) or supraclavicular + distal (Group SD, n=31) group. Patients in group S will receive 32 mL of lidocaine 1.5% + epinephrine 5µg/mL and in group SD receive 20 mL of lidocaine 1.5% + epinephrine 5µg/mL followed by a distal median, radial, and ulnar nerve blocks using 50:50 mixture of lidocaine 2% + levobupivacaine 0.5% (4 mL/nerve). Sensory and motor block of the ulnar, median, radial and musculocutaneous nerves will be assessed every 5 minutes starting at the 10th minutes. The imaging, needling and performance times will be recorded. Also the onset and anesthesia related times, need for analgesic and first analgesic time will be noted.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Feb 2012

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2013

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

October 31, 2013

Completed
21 days until next milestone

First Posted

Study publicly available on registry

November 21, 2013

Completed
Last Updated

November 21, 2013

Status Verified

November 1, 2013

Enrollment Period

1 year

First QC Date

October 31, 2013

Last Update Submit

November 20, 2013

Conditions

Keywords

ultrasoundperipheral nervesanestheticslocal

Outcome Measures

Primary Outcomes (1)

  • The time required after a supraclavicular block alone or a supraclavicular block combined with distal blocks, to achieve a sensory and motor block needed for surgery.

    The onset time of supraclavicular plexus block and the onset time of supraclavicular block combined with distal median, radial, and ulnar nerve blocks will be followed up. The time needed to achieve a surgical block will be assessed in both groups. The difference between the 2 groups will be compared and analysed. For this an investigator blinded to the group allocation will evaluate the sensorial pinprick and motor blocks of the ulnar, median, radial and musculocutaneous nerves every 5 minutes starting at the 10th minutes until 30th minutes.

    All patients will be followed up during the block procedure and during the surgery. Also, after the surgery patients will be followed up to 7 days postoperatively.

Study Arms (2)

supraclavicular block

ACTIVE COMPARATOR

A supraclavicular block with 32 mL of lidocaine 1.5% + epinephrine 5µg/mL was performed for the anaesthetic management of the forearm and hand.

Procedure: intravenous cannulation.Device: Intravenous cannulation.Device: Routine ASA monitoringDrug: Premedication midazolamDrug: LidocaineDrug: Epinephrine

Supraclavicular and median, ulnar, radial blocks

ACTIVE COMPARATOR

Patients in this group received 20 mL of lidocaine 1.5% + epinephrine 5µg/mL for supraclavicular block and after the supraclavicular block they recieved a distal median, radial, and ulnar nerve blocks using 50:50 mixture of lidocaine 2% + levobupivacaine 0.5% (4 mL/nerve).

Procedure: Supraclavicular block and ultrasound-guided ulnar, median and radial nerve blocks.Device: Intravenous cannulation.Device: Routine ASA monitoringDrug: Premedication midazolamDrug: LidocaineDrug: EpinephrineDrug: Levobupivacaine

Interventions

A 18-or 20-gauge intravenous (iv) catheter was placed to the contralateral arm according to the surgical site

supraclavicular block

Supraclavicular block with 20 mL of lidocaine 1.5% + epinephrine 5µg/mL and the addition of ultrasound-guided ulnar, median and radial nerve blocks. For that 12 mL of local anesthetic solution of a 50:50 mixture of lidocaine 2% and levobupivacaine 0.5% (4 mL/nerve) was used.

Supraclavicular and median, ulnar, radial blocks

Monitorization with ECG, noninvasive blood pressure and spO2.

Supraclavicular and median, ulnar, radial blockssupraclavicular block

Premedication with 0.03 mg/kg midazolam iv

Supraclavicular and median, ulnar, radial blockssupraclavicular block
Supraclavicular and median, ulnar, radial blockssupraclavicular block
Supraclavicular and median, ulnar, radial blockssupraclavicular block
Supraclavicular and median, ulnar, radial blocks

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • and 80 years old patient
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Scheduled for elective hand and forearm surgery

You may not qualify if:

  • patient refusal
  • preexisting neuropathy
  • coagulopathy
  • allergy to agents used
  • pregnancy
  • body mass index \> 35 kg/m2
  • chronic obstructive pulmonary disease
  • infection or previous surgery in the supraclavicular area
  • systemic infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara University Faculty of Medicine, Ibni Sina Hospital colonoscopy lab

Ankara, 06700, Turkey (Türkiye)

Location

MeSH Terms

Interventions

LidocaineEpinephrineLevobupivacaine

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesEthanolaminesAmino AlcoholsAlcoholsBiogenic MonoaminesBiogenic AminesCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsBupivacaine

Study Officials

  • Basak Ceyda Meco, MD, DESA

    Ankara University Faculty of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD,DESA

Study Record Dates

First Submitted

October 31, 2013

First Posted

November 21, 2013

Study Start

February 1, 2012

Primary Completion

February 1, 2013

Study Completion

February 1, 2013

Last Updated

November 21, 2013

Record last verified: 2013-11

Locations